紅星美凱龍(01528.HK)控股股東的6.66%股份被凍結
紅星美凱龍(01528.HK)公佈,控股股東紅星控股所持約2.898億股公司股份被凍結,佔公司總股本6.66%。若紅星控股出售予廈門建發(600153.SH)交易相關的股份在交割前進一步出現質押和凍結等權利限制,且無法在交割前解除有關股份的權利限制,相關股份可能存在無法過戶的風險。
集團指,在本月2日收到《股權司法凍結及司法劃轉通知》,紅星控股其中約2.898億股被凍結,涉及申請人方正證券與紅星控股等其他合同糾紛保全需要,案件債權金及執行費用約14.69億元人民幣,股份凍結到期日爲2026年2月1日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.